Medical devices industry M&A deals in June 2020 total $1.81bn globally

21 July 2020 (Last Updated July 21st, 2020 16:30)

Medical devices industry M&A deals in June 2020 total $1.81bn globally

Total medical devices industry M&A deals in June 2020 worth $1.81bn were announced globally, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked an increase of 434.3% over the previous month and a drop of 43.6% when compared with the last 12-month average, which stood at $3.2bn.

Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $1.78bn. At the country level, the US topped the list in terms of deal value at $1.7bn.

In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then South and Central America.

The top country in terms of M&A deals activity in June 2020 was the US with 23 deals, followed by Canada with six and Germany with two.

In 2020, as of the end of June 2020, medical devices M&A deals worth $16.31bn were announced globally, marking a decrease of 29.3% year on year.

Medical devices industry M&A deals in June 2020: Top deals

The top five medical devices industry M&A deals accounted for 97.7% of the overall value during June 2020.

The combined value of the top five medical devices M&A deals stood at $1.77bn, against the overall value of $1.81bn recorded for the month.

The top five medical devices industry deals of June 2020 tracked by GlobalData were:

1) InVitae’s $1.4bn acquisition of ArcherDx

2) The $200m asset transaction with CareZone by Walmart

3) LeMaitre Vascular’s $90m acquisition of Artegraft

4) The $46.74m acquisition of Clarion Medical Technologies by Richards Packaging Income Fund

5) Mach7 Technologies’ acquisition of Client Outlook for $28.69m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.